F-star - About the company
F-star is an acquired company based in Cambridge (United Kingdom), founded in 2006. It operates as a Developer of bispecific antibodies to improve the treatment of cancer. F-star has raised $23.5M in funding from Atlas Venture and SR One. The company has 3463 active competitors, including 1139 funded and 795 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Kite Pharma.
Company Details
Developer of bispecific antibodies to improve the treatment of cancer. The company is developing antibody products to improve the treatment of serious diseases, with a focus on immuno-oncology and inflammation. The company's modular antibody technology allows for rapid discovery and develops bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company's lead program is FS118, that targets immune checkpoints (LAG-3) and PD-1 for the treatment of head and neck cancer.
- Website
- f-star.com
- Social
- Registered Address
- 245 First Street Riverview II, Floor 18 Cambridge, MA 02142
Key Metrics
Founded Year
2006
Location
Cambridge, United Kingdom
Stage
Acquired
Total Funding
$23.5M in 2 rounds
Latest Funding Round
Investors
Ranked
958th among 3463 active competitors
Annual Revenue
£1M - £10M as on Dec 31, 2025
Employee Count
9 as on Sep 30, 2026
Similar Companies
Exit Details
Acquired by invoX Pharma (Jun 23, 2022)
Legal entities associated with F-star
F-star is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
F-star Therapeutics Limited CIN: 11532458 , United Kingdom, Active | Aug 21, 2018 | £1M - £10M (As on Dec 31, 2025) | 71 (As on Jan 31, 2021) | |
F-Star Therapeutics Inc. CIN: 4557165 , United States, Active | May 11, 2008 | - | 80 (As on Mar 31, 2022) | - |
F-star Biotechnology Limited CIN: 08067987 , Germany, Active | May 13, 2012 | £10M - £50M (As on Dec 31, 2018) | 80 (As on Mar 31, 2022) |
F-star's acquisition details
F-star got acquired by invoX Pharma on Jun 23, 2022 at an acquisition amount of $*****.
Click here to take a look at F-star's acquisition in detail
Sign up to download F-star's company profile
F-star's funding and investors
F-star has raised a total funding of $23.5M over 2 rounds. Its first funding round was on Jan 08, 2006. Its latest funding round was a Series B round on Apr 13, 2011 for $*****. 7 investors participated in its latest round. F-star has 11 institutional investors.
Here is the list of recent funding rounds of F-star:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 13, 2011 | 2920061 | Series B | 5471985 | 6062976 | 1120824 | 5838082 |
Jan 08, 2006 | 3804567 | Seed | 1114486 | 5668610 | 4236632 |
Access funding benchmarks and valuations. Sign up today!View details of F-star's funding rounds and investors
F-star's founders and board of directors
Founder? Claim ProfileHere are the details of F-star's key team members:
- Eliot Forster: ex-CEO of F-star. They are also an angel investor in 1 startup.
- John Haurum: CEO of F-star. They serve on the board of 1 company.
F-star's Board of Directors
F-star's board has 2 active members. Eliot Richard Forster is part of team and John Paul Fitzpatrick is independent board member.Here is the list of F-star's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
odjicwq | Team | - | Current | 8y 5m |
nguqalm | Team | - | Past | 4y 2m |
isftzru | Team | - | Past | 7y 2m |
jxciwjt | Team | - | Past | 6y 5m |
Independent board member | - | Current | 6y 6m | |
{hgltvb | Independent board member | - | Past | 2y 9m |
View details of F-star's Founder profiles and Board Members
F-star's employee count trend
F-star has 9 employees as of Sep 26. Here is F-star's employee count trend over the years:
Uncover F-star's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
F-star's Competitors and alternates
Top competitors of F-star include Jazz Pharmaceuticals, BeiGene and Kite Pharma. Here is the list of Top 10 competitors of F-star, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 77/100 | |
3rd | Kite Pharma 2009, Los Angeles (United States), Acquired | Developer of cancer immunotherapy products using genetic engineering | $97.7M | 76/100 | |
4th |  Attovia 2023, Fremont (United States), Public | Developer of antibody-based therapeutics for immune-mediated diseases and oncology | $255M | 72/100 | |
5th |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | 72/100 | |
6th |  Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 72/100 | |
7th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
8th | Developer of immunotherapeutics for the treatment of cancer and other diseases | $861M | 71/100 | ||
9th | _1545299782322.png?devicePixelRatio=2&height=30&width=30){kind=logo} Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
10th |  Strand Therapeutics 2017, Cambridge (United States), Series B | Provider of platform to deliver mRNA therapeutics for multi functional treatments | $256M | 71/100 | |
958th | F-star 2006, Cambridge (United Kingdom), Acquired | Developer of bispecific antibodies to improve the treatment of cancer | $23.5M | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on F-star's competitors? Click here to see the top ones
F-star's Investments and acquisitions
F-star has made no investments or acquisitions yet.
Reports related to F-star
Here is the latest report on F-star's sector:
News related to F-star
Filter this list•
F-star management takes company private, two years after $161M cash exit to Sino's invoXEndPoints News•Apr 04, 2025•F-star, invoX Pharma
•
•
Takeda adds another F-star collab to constellation, this time for $1B biobucksFierce Biotech•Jul 06, 2023•F-star, Takeda, Sino Biopharmaceutical
•
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of DirectorsACROFAN•May 16, 2023•Ochre Bio, F-star
•
F-star Therapeutics cashes in on new Takeda dealBusiness Weekly newspaper•Apr 06, 2023•F-star, Takeda
•
•
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaGlobeNewswire•Mar 07, 2023•F-star, invoX Pharma
•
F-star Therapeutics jumps as it extends walk date with buyer to `finalize' CFIUS agreementSeeking Alpha•Feb 24, 2023•F-star, invoX Pharma
•
F-star Therapeutics gains as buyer Sino Biopharma cancels Shanghai listingSeeking Alpha•Feb 08, 2023•Sino Biopharmaceutical, F-star
•
invoX Pharma and F-star Therapeutics issue Joint StatementGlobeNewswire•Jan 27, 2023•F-star, invoX Pharma
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about F-star
Explore our recently published companies
- DIV Protocol - Paris based, 2025 founded, Unfunded company
- D and H Fire - San Dimas based, 2016 founded, Funding Raised company
- Eye7 Eye Hospitals - Delhi based, 1987 founded, Unfunded company
- AiLuvio - Praha based, 2023 founded, Unfunded company
- Receptive Sports Technologies - Ludhiana based, 2022 founded, Unfunded company
- Goods For Health - Delhi based, 2025 founded, Unfunded company
